SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Fate Therapeutics Presents Updated Preliminary FT819 Data in Lupus Nephritis

Fate Therapeutics presented updated preliminary data for FT819 in active lupus nephritis at ASN Kidney Week 2026. The supplied body is truncated.

FATE

Related stories